Enhancer Detail

Comprehensive information about experimentally validated enhancers

About Enhancer
Enhancer ID: E_00230
Species: Homo sapiens
Position : chr2:217994794-217995294
Year: 2021
Title: Functional annotation of the 2q35 breast cancer risk locus implicates a structural variant in influencing activity of a long-range enhancer element
Genome Build: hg19
Enhancer Type: Enhancer
Condition: Disease
Disease Name: breast carcinoma
PMID:  34146516
MONDO: MONDO:0006120
Tissue: Breast
Tissue Ontology ID: UBERON:0000310
Cell Source: MCF7
CVCL ID: CVCL_0031
Cell Type: breast carcinoma cell
Cell Ontology ID: CL:0000066
Experiment Type: Enhancer activity assay, Functional perturbation assay
High Throughput Method: ChIP-seq, RNA-seq
Low Throughput Method: Luciferase Reporter Assay, CRISPRa, RT-RT-qPCR
About Target Gene
Target gene : IGFBP5
About TF
TF name : FOXA1
About Regulatory State
Regulatory State : Active
Upstream Pathway Annotation of TF
GeneName Pathway Name Source Gene Number
FOXA1 AndrogenReceptor netpath 167
FOXA1 Direct p53 effectors pid 141
FOXA1 FOXA1 transcription factor network pid 45
FOXA1 FOXA2 and FOXA3 transcription factor networks pid 45
FOXA1 Hs_Endoderm_Differentiation_WP2853_88152 wikipathways 62
Enhancer Associated Network
Overlapping Enhancers (hg19) 1 found
Enhancer ID Position Tissue Cell Disease
E_00231 chr2:217994794-217995294 Breast breast carcinoma cell breast carcinoma
Expression of Target Genes for the Enhancer